Skip to main content
Explore URMC

menu

Study of Immunotherapy + Radiation in Soft Tissue Cancer

Research Question:
What is the effect of immunotherapies with concurrent radiation followed by surgical removal of soft tissue cancer?

Basic Study Information

Purpose:
The main aim of immunotherapy is to enable patients' immune system to target cancer cells and destroy them. This study will treat patients with soft tissue sarcoma (cancer) with neoadjuvant nivolumab and ipilimumab, antibodies that can be used as immunotherapies. Patients will also receive concurrent radiation therapy. Following these treatments will be the surgical removal of the patent's soft tissue sarcoma.

Location: University of Rochester Medical Center
Study Reference #: USAR-17101

Lead Researcher (Principal Investigator)

Lead Researcher: Deepak Sahasrabudhe, MD

Study Contact Information

Study Coordinator: Park Bogan
Phone: (585) 276-4415
Email: Park_Bogan@URMC.Rochester.edu

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search